Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study-Reference-Cited by-同舟云学术

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Published:2019-04-09 Issue:6 Volume:49 Page:617-626
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ogawa Eiichi¹,Furusyo Norihiro¹,Nakamuta Makoto²,Nomura Hideyuki³,Satoh Takeaki⁴,Takahashi Kazuhiro⁵,Koyanagi Toshimasa⁶,Kajiwara Eiji⁷,Dohmen Kazufumi⁸,Kawano Akira⁹,Ooho Aritsune¹⁰,Azuma Koichi¹¹,Kato Masaki¹²,Shimoda Shinji¹³,Hayashi Jun¹⁴,

Affiliation:

1. Department of General Internal MedicineKyushu University Hospital Fukuoka Japan

2. Department of GastroenterologyKyushu Medical Center, National Hospital Organization Fukuoka Japan

3. The Center for Liver DiseaseShin‐Kokura Hospital Kitakyushu Japan

4. Center for Liver DiseaseNational Hospital Organization Kokura Medical Center Kitakyushu Japan

5. Department of MedicineHamanomachi Hospital Fukuoka Japan

6. Department of MedicineFukuoka City Hospital Fukuoka Japan

7. Kajiwara Clinic Kitakyushu Japan

8. Department of Internal MedicineChihaya Hospital Fukuoka Japan

9. Department of MedicineKitakyushu Municipal Medical Center Kitakyushu Japan

10. Department of HepatologySteel Memorial Yawata Hospital Kitakyushu Japan

11. Department of MedicineKyushu Central Hospital Fukuoka Japan

12. Department of Medicine and Bioregulatory Science, Graduate School of Medical SciencesKyushu University Fukuoka Japan

13. Department of Medicine and Biosystemic Science, Graduate School of Medical SciencesKyushu University Fukuoka Japan

14. Kyushu General Internal Medicine CenterHaradoi Hospital Fukuoka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13328

Reference28 articles.

1. Hepatitis C Virus Infection

2. Hepatitis C

3. HCV direct-acting antiviral agents: the best interferon-free combinations

4. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

5. Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid;Viruses;2023-02-09

3. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

4. Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir;Internal Medicine;2023

5. Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older;BMC Gastroenterology;2022-04-28